Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-01-21Clinical Trial Update: Quetiapine vs Haloperidol Decanoate for the Long Term Treatment of Schizophrenia and Schizoaffective Disorder [NA]
This completed head-to-head clinical trial compares quetiapine with haloperidol decanoate for long-term treatment of schizophrenia and schiz…
-
CLINICAL_TRIALS trial_result · 2009-01-21Clinical Trial Update: 5HT3 Antagonism and Auditory Gating in Schizophrenia [NA]
A completed clinical trial update evaluating 5-HT3 receptor antagonism and auditory gating in schizophrenia.
-
CLINICAL_TRIALS trial_result · 2009-01-21Clinical Trial Update: Brief Hospitalization for Schizophrenia: Strategies to Improve Treatment Outcome [NA]
A completed clinical trial evaluating strategies to improve treatment outcomes during brief hospitalization for schizophrenia.
-
CLINICAL_TRIALS trial_result · 2009-01-21Clinical Trial Update: Antipsychotic Response in Schizophrenia [Phase 4]
The document reports the completion of a Phase 4 clinical trial assessing antipsychotic response in schizophrenia.
-
CLINICAL_TRIALS trial_result · 2009-01-21Clinical Trial Update: Generalization of Training in Schizophrenia [NA]
A completed clinical trial examining the generalization of training interventions in people with schizophrenia and schizoaffective disorder.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2009-01-13Clinical Trial Update: Shiatsu Adjuvant Therapy And Placebo For Schizophrenia [NA]
Clinical trial update on shiatsu adjuvant therapy for schizophrenia; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2009-01-07Clinical Trial Update: Cognitive - Behavioral Therapy [Phase 2]
Phase 2 trial evaluating cognitive-behavioral therapy for schizoaffective disorder and schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2008-12-29Clinical Trial Update: Social Functioning in Schizophrenia
This clinical trial update notes the completion of a study evaluating social functioning in schizophrenia.
-
CLINICAL_TRIALS research · 2008-12-29Clinical Trial Update: Qualitative Analysis on the Experiences of Employment Among Schizophrenic Patients
A completed qualitative study examining the employment experiences of individuals with schizophrenia.
-
CLINICAL_TRIALS trial_result · 2008-12-18Clinical Trial Update: Memantine as Adjunctive Therapy for Schizophrenia Negative Symptoms [Phase 4]
Phase 4 trial evaluating memantine as adjunctive therapy for negative symptoms in schizophrenia has completed.
-
CLINICAL_TRIALS research · 2008-12-16Clinical Trial Update: L-Theanine in the Management of Schizophrenia [Phase 3]
Phase 3 clinical trial update indicating completion of a study evaluating L-Theanine in schizophrenia.
-
CLINICAL_TRIALS trial_result · 2008-12-11Clinical Trial Update: Injectable Naltrexone Treatment of Alcohol Dependence in Serious Mental Illness (SMI) [Phase 4]
This clinical trial update reports the completion of a Phase 4 study evaluating injectable naltrexone for alcohol dependence in individuals …
-
CLINICAL_TRIALS trial_result · 2008-11-25Clinical Trial Update: Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia [Phase 2]
Phase 2 proof-of-concept trial to evaluate cognitive improvement in patients with schizophrenia. The study has been completed.
-
FDA approval · 2008-11-25FDA Approved: PERPHENAZINE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for PERPHENAZINE submitted by Sandoz Inc.
-
FDA approval · 2008-11-25FDA Approved: TRIFLUOPERAZINE HYDROCHLORIDE — Supplemental Application (Sandoz Inc.)
FDA approved a supplemental application for trifluoperazine hydrochloride from Sandoz Inc., confirming an additional approval for this gener…
-
FDA approval · 2008-11-25FDA Approved: TRIFLUOPERAZINE HYDROCHLORIDE — Supplemental Application (Sandoz Inc.)
FDA approved a supplemental application for trifluoperazine hydrochloride from Sandoz Inc., a generic antipsychotic. The action confirms reg…
-
FDA approval · 2008-11-25FDA Approved: TRIFLUOPERAZINE HYDROCHLORIDE — Supplemental Application (Sandoz Inc.)
FDA approved a supplemental application for trifluoperazine hydrochloride from Sandoz Inc., updating the product’s status accordingly.
-
FDA approval · 2008-11-25FDA Approved: HALOPERIDOL — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)
FDA approved a supplemental application for HALOPERIDOL (generic) from PAI Holdings, LLC dba PAI Pharma under ANDA073037.
-
FDA approval · 2008-11-19FDA Approved: PERPHENAZINE — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for perphenazine submitted by Sandoz Inc to support continued marketing of the drug.
-
FDA approval · 2008-11-19FDA Approved: LOXAPINE — Supplemental Application (Elite Laboratories, Inc.)
FDA approved a supplemental application for LOXAPINE (loxapine) by Elite Laboratories, Inc. under ANDA076868, approving changes to the gener…
-
FDA approval · 2008-11-19FDA Approved: CHLORPROMAZINE HYDROCHLORIDE — Supplemental Application (Upsher-Smith Laboratories, LLC)
The FDA approved a supplemental application for chlorpromazine hydrochloride (Upsher-Smith Laboratories, LLC).
-
FDA approval · 2008-11-19FDA Approved: CHLORPROMAZINE HYDROCHLORIDE — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for chlorpromazine hydrochloride from Upsher-Smith Laboratories, approving changes to the approved d…
-
FDA approval · 2008-11-19FDA Approved: HALOPERIDOL DECANOATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Haloperidol decanoate by Hikma Pharmaceuticals USA Inc., indicating the supplement has been appr…
-
FDA approval · 2008-11-19FDA Approved: CHLORPROMAZINE HYDROCHLORIDE — Supplemental Application (Upsher-Smith Laboratories, LLC)
The FDA approved a supplemental application for chlorpromazine hydrochloride from Upsher-Smith Laboratories, LLC. This action updates the ap…
-
FDA approval · 2008-11-19FDA Approved: CLOZAPINE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for Clozapine by Mylan Pharmaceuticals Inc., granting approval for a generic Clozapine product.